8. When does the period of 3 years for market introduction of MP commence pursuant to Section 34a (1) of the Act on Pharmaceuticals for generic medicinal products?

The provision in Section 34a (1) of the Act on Pharmaceuticals stipulates that the period for a generic medicinal product shall commence only on the day on which the period in which it may not be introduced to the market pursuant to Section 27 (1) of the Act on Pharmaceuticals terminates. We kindly ask the marketing authorisation holder to contact SUKL staff by e-mail should they establishes any discrepancies.